business finance FIN 350 discussion board

FRB Sales Page 1 of 3

0-1MM 1-3MM 3-5MM 5-10MM 10-25MM 25MM and Over All Type of Statement Unqualified 1 3 3 5 29 41 Reviewed 1 1 7 9 18 Compiled 1 3 4 1 3 12 Tax Returns 1 2 4 2 9 Other 2 3 9 16 64 94

27 (4/1-9/30/13) Number of Statements 1 4 12 21 31 105 174 ASSETS Cash & Equivalents 14.5 8.7 17.7 14.5 14.2 Trade Receivables - (net) 23.7 20.5 17.7 20.7 20.3 Inventory 18.1 22.6 19.5 20.9 20.8 All Other Current Assets 3.1 1.3 2.8 3.6 3.1 Total Current Assets 59.3 53.0 57.8 59.7 58.4 Fixed Assets (net) 19.3 29.2 31.4 20.8 23.9 Intangibles (net) 9.3 9.2 4.6 13.3 10.9 All Other Non-Current Assets 12.0 8.6 6.3 6.1 6.8 Total Assets 100.0 100.0 100.0 100.0 100.0 LIABILITIES Notes Payable-Short Term 6.5 9.3 4.8 4.5 5.5 Cur. Mat.-L/T/D 1.7 3.5 3.0 6.4 5.0 Trade Payables 14.1 13.3 10.3 15.4 13.9 Income Taxes Payable .2 .0 .1 .4 .3 All Other Current Liabilities 5.9 8.4 11.0 11.5 10.6 Total Current Liabilities 28.4 34.6 29.2 38.3 35.2 Long Term Debt 16.5 14.6 16.0 16.4 17.4 Deferred Taxes .4 .2 .1 1.4 .9 All Other Non-Current Liabilities 7.8 5.9 3.1 6.2 5.7 Net Worth 47.0 44.7 51.6 37.8 40.8 Total Liabilities & Net Worth 100.0 100.0 100.0 100.0 100.0 INCOME DATA Net Sales 100.0 100.0 100.0 100.0 100.0 Gross Profit 49.6 44.5 52.8 46.0 47.4 Operating Expenses 38.7 41.0 41.1 33.7 36.4 Operating Profit 10.9 3.4 11.7 12.3 11.0 All Other Expenses (net) 1.8 .4 -.6 2.7 1.8 Profit Before Taxes 9.1 3.0 12.3 9.6 9.2 RATIOS Current - upper 3.8 2.5 4.0 3.4 3.4

325412 - Pharmaceutical Preparation Manufacturing 2014-15 Annual Statement Studies

National - All Regions

Week 7

Week 8

Week 8

Week 8

Week 5

FRB Sales Page 2 of 3

0-1MM 1-3MM 3-5MM 5-10MM 10-25MM 25MM and Over All

325412 - Pharmaceutical Preparation Manufacturing 2014-15 Annual Statement Studies

National - All Regions

Current - median 2.0 1.6 1.9 1.9 1.9 Current - lower 1.5 1.2 1.0 1.2 1.2 Quick - upper 2.4 1.5 2.4 2.1 2.0 Quick - median 1.3 1.0 1.1 1.0 1.0 Quick - lower .7 .6 .6 .6 .6 Sales / Receivables - upper [27] 13.6 [27] 13.6 [24] 15.5 [33] 10.9 [31] 11.7 Sales / Receivables - median [35] 10.5 [39] 9.4 [37] 9.9 [45] 8.2 [42] 8.7 Sales / Receivables - lower [55] 6.6 [54] 6.7 [49] 7.5 [60] 6.1 [57] 6.4 Cost of Sales / Inventory - upper [37] 9.9 [4] 85.3 [33] 11.1 [54] 6.7 [47] 7.7 Cost of Sales / Inventory - median [66] 5.5 [55] 6.6 [91] 4.0 [91] 4.0 [89] 4.1 Cost of Sales / Inventory - lower [104] 3.5 [99] 3.7 [146] 2.5 [130] 2.8 [126] 2.9 Cost of Sales / Payables - upper [30] 12.3 [20] 18.7 [15] 24.7 [28] 12.9 [25] 14.5 Cost of Sales / Payables - median [36] 10.0 [36] 10.1 [26] 13.8 [44] 8.3 [39] 9.3 Cost of Sales / Payables - lower [61] 6.0 [70] 5.2 [46] 7.9 [68] 5.4 [65] 5.6 Sales / Working Capital - upper 4.9 5.8 3.7 3.2 3.7 Sales / Working Capital - median 9.3 13.3 7.1 7.3 7.5 Sales / Working Capital - lower 21.1 66.2 999.8 31.9 26.9 EBIT / Interest - upper 97.1 6.7 50.8 44.1 39.7 EBIT / Interest - median (10) 11.4 (17) 3.9 (27) 6.3 (88) 8.1 (145) 6.4 EBIT / Interest - lower 3.1 -5.4 2.1 2.1 1.8 Net Profit + DDA / Curr Mat LTD - upper 11.2 10.5 Net Profit + DDA / Curr Mat LTD - median (48) 4.0 (62) 4.3 Net Profit + DDA / Curr Mat LTD - lower 1.2 1.4 Fixed / Worth - upper .1 .2 .3 .2 .2 Fixed / Worth - median .3 .7 .7 .7 .6 Fixed / Worth - lower .6 2.1 1.6 16.2 2.7 Debt / Worth - upper .4 .9 .4 .5 .5 Debt / Worth - median 1.5 1.3 .9 1.6 1.3 Debt / Worth - lower 7.2 3.3 3.4 63.5 8.5 % Profit before Taxes / Tangible Net Worth - upper 84.8 59.5 71.4 62.9 63.2 % Profit before Taxes / Tangible Net Worth - median (11) 23.3 (18) 11.6 (29) 32.4 (83) 23.5 (145) 23.5 % Profit before Taxes / Tangible Net Worth - lower 7.0 -11.8 11.2 12.2 9.1 % Profit before Taxes / Total Assets - upper 23.7 16.0 33.2 21.7 23.6 % Profit before Taxes / Total Assets - median 8.9 8.5 14.1 9.8 9.8 % Profit before Taxes / Total Assets - lower 3.5 -6.3 4.3 3.4 2.9 Sales / Net Fixed Assets - upper 82.9 32.3 19.3 28.8 29.1 Sales / Net Fixed Assets - median 15.3 16.0 6.6 10.3 9.8 Sales / Net Fixed Assets - lower 6.9 3.5 3.5 4.2 4.2 Sales / Total Assets - upper 3.0 3.2 2.2 2.3 2.5

Week 5

Week 6

Week 7

Week 8

Week 8

Week 6

FRB Sales Page 3 of 3

0-1MM 1-3MM 3-5MM 5-10MM 10-25MM 25MM and Over All

325412 - Pharmaceutical Preparation Manufacturing 2014-15 Annual Statement Studies

National - All Regions

Sales / Total Assets - median 2.3 2.0 1.5 1.5 1.7 Sales / Total Assets - lower 1.4 1.3 1.1 .9 1.0 % Depr, Depl, Amort / Sales - upper 1.0 1.2 1.0 1.0 % Depr, Depl, Amort / Sales - median (18) 1.4 (26) 2.3 (87) 2.1 (143) 2.0 % Depr, Depl, Amort / Sales - lower 6.0 4.2 3.5 3.7 % Officers', Directors', Owners' Comp / Sales - upper 1.9 .9 1.4 % Officers', Directors', Owners' Comp / Sales - median (10) 2.7 (12) 1.6 (36) 2.4 % Officers', Directors', Owners' Comp / Sales - lower 3.7 4.0 3.6 Net Sales ($) 22M 7389M 51781M 142960M 505328M 8891011M 9598491M Total Assets ($) 43M 4820M 48662M 84858M 394722M 6781121M 7314226M

Week 6